Somatostatin therapy in l‐asparaginase‐induced pancreatitis
1994; Alan R. Liss, Inc.; Volume: 22; Issue: 6 Linguagem: Inglês
10.1002/mpo.2950220614
ISSN1096-911X
AutoresYiu‐fai Cheung, Acw Lee, Gcf Chan, Karen K. L. Chan, YL Lau, C. Y. Yeung,
Tópico(s)Neonatal Health and Biochemistry
ResumoAbstract L‐Asparaginase‐induced pancreatitis is an uncommon but potentially lethal complication. An 8‐year‐old girl with acute lymphoblastic leukaemia developed acute pancreatitis following treatment with asparaginase. Clinical and laboratory improvements were evident after treatment with somatostatin, with no complications of pancreatitis. Induction therapy for the leukaemia was able to be continued and complete remission was documented during the course of pancreatitis and somatostatin treatment, suggesting a beneficial role of somatostatin in the management of asparaginase‐induced pancreatitis. © 1994 Wiley‐Liss, inc.
Referência(s)